← Leaderboards
Cristina D'abramo
Feinstein Institute For Medical Research
$2,920,930
Attributed
$2,920,930
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $626.1K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,920,930 · 2
By mechanism
R01$2,508,430 · 1
R56$412,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Betty Diamond$68,537,262
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposPreventMonoclonal AntibodiesTauopathiesBrainRecombinantsPathologyParentsS DiseaseS Disease ModelImmunotherapyIn VitroTau ProteinsAntibodiesEpitopesExtracellular ProteinNeurodegenerative DisordersNeurofibrillary TanglesCostLightInflammatoryLaboratoriesMicrogliaBlood-Brain Barrier Penetration
Grant awards (7)
Vectorized scFv antibodies to treat tau pathology in Alzheimer's disease: enhancing epitope targeting and delivery strategies$626,060
R01 · FY2024 · AG · contact PI
Vectorized scFv antibodies to treat tau pathology in Alzheimer's disease: enhancing epitope targeting and delivery strategies$418,750
R01 · FY2023 · AG · contact PI
Vectorized scFv antibodies to treat tau pathology in Alzheimers disease enhancing epitope targeting and delivery strategies$207,370
R01 · FY2023 · AG · contact PI
Vectorized scFv antibodies to treat tau pathology in Alzheimer's disease: enhancing epitope targeting and delivery strategies$418,750
R01 · FY2022 · AG · contact PI
Vectorized scFv antibodies to treat tau pathology in Alzheimer's disease: enhancing epitope targeting and delivery strategies$418,750
R01 · FY2021 · AG · contact PI
Vectorized scFv antibodies to treat tau pathology in Alzheimer's disease: enhancing epitope targeting and delivery strategies$418,750
R01 · FY2020 · AG · contact PI
Immunotherapy in Alzheimer's Disease Animal Models Using Tau Recombinant Antibodies$412,500
R56 · FY2017 · AG · contact PI